flutamide and procarbazine

flutamide has been researched along with procarbazine in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (40.00)18.2507
2000's3 (30.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Cespedes, RD; Jackson, C; Peretsman, SJ; Thompson, IM1
Huhtaniemi, I; Kangasniemi, M; Meistrich, ML; Wilson, G1
Huhtaniemi, I; Kangasniemi, M; Meistrich, ML; Parchuri, N; Wilson, G1
Denis, L1
Akay, AF; Bircan, MK; Deniz, M; Göçmen, M; Nergiz, Y; Sahin, H1

Reviews

1 review(s) available for flutamide and procarbazine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for flutamide and procarbazine

ArticleYear
European Organization for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996.
    Urology, 1998, Volume: 51, Issue:5A Suppl

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Castration; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Epirubicin; Estramustine; Flutamide; Humans; Imidazoles; Male; Medroxyprogesterone Acetate; Methotrexate; Mitomycin; Neoplasms, Hormone-Dependent; Procarbazine; Prostatic Neoplasms; Vindesine

1998

Other Studies

8 other study(ies) available for flutamide and procarbazine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Protection of the germinal epithelium in the rat from the cytotoxic effects of chemotherapy by a luteinizing hormone-releasing hormone agonist and antiandrogen therapy.
    Urology, 1995, Volume: 46, Issue:5

    Topics: Animals; Drug Therapy, Combination; Epithelium; Flutamide; Goserelin; Male; Procarbazine; Rats; Rats, Sprague-Dawley; Seminiferous Tubules

1995
Protection against procarbazine-induced testicular damage by GnRH-agonist and antiandrogen treatment in the rat.
    Endocrinology, 1995, Volume: 136, Issue:8

    Topics: Androgen Antagonists; Animals; Drug Combinations; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Hormones; Male; Procarbazine; Rats; Spermatogenesis; Testis

1995
Rapid protection of rat spermatogenic stem cells against procarbazine by treatment with a gonadotropin-releasing hormone antagonist (Nal-Glu) and an antiandrogen (flutamide).
    Endocrinology, 1995, Volume: 136, Issue:7

    Topics: Animals; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Kinetics; Male; Organ Size; Procarbazine; Rats; Rats, Inbred BN; Rats, Inbred Lew; Spermatogenesis; Spermatozoa; Stem Cells; Testis; Testosterone

1995
The effects of GnRH analogues and antiandrogenes in preventing the gonadotoxic effects of COPP chemotherapy.
    International urology and nephrology, 2001, Volume: 33, Issue:4

    Topics: Androgen Antagonists; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Flutamide; Goserelin; Male; Prednisone; Procarbazine; Random Allocation; Rats; Rats, Sprague-Dawley; Vincristine

2001